Group items tagged

Paul Rees MBE has joined the National Pharmacy Association (NPA) today (27 November) as its new Chief Executive. Current NPA Chief Executive Mark Lyonette, who is retiring, will remain at the NPA for some weeks in order to ensure a smooth handover. Previously, Paul has worked as the Chief Executive of the Royal College of Psychiatrists for the seven years. On joining NPA, Paul said: "It is a great privilege and honour to take up the position of NPA Chief Executive. The association is the voice of independent community pharmacy and is core to the sector's future success in England, Scotland, Wales and Northern Ireland. "I am delighted that the NPA has placed its trust in me and I intend to deliver for NPA members, for the sector and for society at large, which relies on there being a vibrant community pharmacy network in villages, towns and cities across the four nations of the UK." When Paul's appointment was first announced in September, NPA Chair Nick Kaye said that they identified him as an "excellent fit for our organisation" after a rigorous recruitment process, and also thanked Mark for his "great work as chief exec since 2018."

The National Pharmacy Association (NPA) has announced the retirement of its Chief Executive, Mark Lyonette. Mark will retire in 2024. The association has announced his retirement well in advance so that the Board can start work with a leading recruitment agency to search for the new Chief Executive. "The Board is keen to build on the strong foundations established and ensure there is a seamless transition and minimum disruption to the business once the new Chief Executive is in post," said the association. Mark said: "After five years at the NPA and 40 years working for and leading national membership organisations, I am looking forward to living a different life. "I am pleased that in the time that I have been with the NPA we have grown both the membership and customer base and created a profitable, stable membership organisation. "Alongside our NPA Insurance company, the association is well set to help members face the future. "Meanwhile there is much to do to ensure that 2023 is another good year in terms of the NPA delivering consistently for members. The process of changing Chief Executive won't deflect us from our vital work."

The National Pharmacy Association (NPA) has appointed Paul Rees MBE as its new Chief Executive, with his role commencing on November 27th. Rees, currently serving as the Chief Executive of the Royal College of Psychiatrists and having held various roles throughout his career, will succeed Mark Lyonette, who is retiring, NPA said in a statement. "We anticipate Paul joining the NPA after a thorough recruitment process affirmed his suitability," said Nick Kaye, Chair of NPA. "Throughout his career, including his role at the Royal College of Psychiatrists, he has made a significant impact and achieved concrete changes in healthcare and society. I would also like to express my appreciation to Mark for his work as Chief Executive since 2018. He still has important tasks to complete at the NPA before his retirement." Rees has also held key positions at prominent organisations, including the Ramblers Association, National Housing Federation, Charities Aid Foundation, Association of University Teachers, and the , besides being the Head of Communications at the Home Office.

Alitam Group, the 100-plus pharmacy store consolidation, has appointed Bharti Patel, the former group executive director of Avicenna to its executive board. Patel, who was part of the leadership team at Avicenna until late 2021, brings with her a wealth of experience covering pharmaceuticals, multiple retail and independent pharmacy, homecare and NHS primary and secondary care. In her early career, she worked at Lloyds Pharmacy, where she rose from a prescription medicines buyer to director of procurement over a period of eight years. She is known in the industry for her strong leadership, commercial acumen and ability to create opportunities for innovation and strategic partnerships. Alitam founder and CEO Feisal Nahaboo said in a statement that Patel's appointment will further strengthen the group's ability to deliver its transformative multi-billion-pound 'Pharmacy of the Future' concept.

Paul Rees MBE, chief executive of the National Pharmacy Association (NPA), has announced his resignation to take on a new role as interim chief executive and registrar of the Nursing and Midwifery Council (NMC) in the new year. He will join the NMC on a one-year contract starting January 20, where he will oversee the development of a multi-year programme aimed at transforming the NMC's culture and performance. This follows an independent culture review conducted by Nazir Afzal OBE, which highlighted issues of racism, discrimination, and bullying within the organisation. The NPA is engaging a leading recruitment agency to find its next chief executive, with plans to make an appointment early in the New Year. NPA chair Nick Kaye praised Paul's contributions over the last year, stating: "I'm enormously grateful to Paul and the brilliant NPA team who are doing so much to raise the profile of community pharmacy, campaign for a better deal and improve our outstanding support to members. "Our board and senior team are pressing ahead with our very successful campaigning and our work to transform the support and services we give to pharmacies across the country.

The Pharmaceutical Society NI (PSNI) has announced that Michaela McAleer will be replacing Trevor Patterson as Chief Executive of PSNI. After 15 years at the helm, Patterson announced his intention to retire. Jonathan Patton, Vice President of the Society said, "Joining the Society from the construction sector Trevor brought fresh thinking and vigour to the Society and quickly established his credibility with pharmacists, Council, stakeholders and fellow regulatory bodies." "Trevor has presided over tremendous change and development through his tenure with equal measures of professionalism and passion on creating safer protections for the public and ensuring pharmacists achieved world class standards in their profession. We are saddened to see him depart but on behalf of Council I wish him a long and healthy retirement and wish him well in the next chapter of life. We are indebted to him for his dedication to the Pharmaceutical Society NI." "Losing the constant and continuity of our 15 year serving Chief Executive ushers in a time of change and evolution for us as the Pharmacy Regulator. We are in the midst of a fast moving and changing environment as we implement continuous improvement.

The General Pharmaceutical Council is appointing a new Chief Pharmacy Officer to strengthen the professional voice within the senior leadership team. This introduction is aimed at fostering a culture of enterprise leadership, inclusion and collaboration within the organisation, GPhC said in a statement. According to GPhC, the Chief Pharmacy Officer will serve as the authoritative representative of the pharmacy regulator in public, within the pharmacy professions, and increasingly in multi-disciplinary teams and collaborative regulatory work. "They will act as the executive lead on pharmacy inspection and regulatory insight, providing professional leadership within the GPhC and collaborating closely with pharmacist and pharmacy technician colleagues across the organisation." The Chief Pharmacy Officer, reporting to the Chief Executive and Registrar, will hold the highest professional position within the GPhC executive, providing pharmacy leadership across the organisation, GPhC said.

Rosalind Brewer, the CEO of Walgreens Boots Alliance, Inc. (WBA), the parent company of Boots UK, has resigned from her position after serving for less than three years. The prominent US pharmaceutical company is currently in the process of searching for her successor. Ginger Graham, the lead independent director, has been appointed as the interim CEO. "WBA's board of directors and Brewer have mutually agreed on her departure as chief executive and board member," the company said in a statement. Brewer officially stepped down from her roles as chief executive and director on Thursday (Aug. 31). She assumed the CEO role in March 2021, succeeding Executive Chairman Stefano Pessina. Prior to this, Brewer held the position of CEO at Starbucks. The leadership change aligns with WBA's shift towards becoming a broader healthcare company, a strategic move initiated by Brewer and her team in October 2021.

Orphan Drug development specialist TMC Pharma has appointed Gordon Cameron to its board as a non-executive director. Mr Cameron has 25 years' board-level experience in biotech and pharmaceutical services sectors. He started his career with EY, then spent several years in investment banking at Rothschild before becoming CFO, and then CEO, of international vaccine company Acambis. For the past 15 years, Mr Cameron has been CFO of Quotient Sciences, an international Contract Development and Manufacturing Organisation and Clinical Research Organisation. In 2004, he was awarded the Officer of the Order of the British Empire for services to the British biotechnology industry. Julie Matthews, chief executive officer of TMC Pharma, said that the new appointment would "enhance our strategic capability and tactical execution as we consolidate our position as a global leader in the Orphan Drug development market."

The UK Health Security Agency's (UKHSA) Chief Executive, Professor Dame Jenny Harries has expressed concern that measles outbreak could spread to other towns and cities unless urgent action is taken to increase Measles, Mumps and Rubella (MMR) vaccination uptake in areas at greatest risk. The virus can spread very easily among those who are unvaccinated, especially in nurseries and schools, she said on Friday (19 January) during a visit to irmingham to review the ongoing work to contain the spread of the disease. A rapid rise in cases has been seen in the West Midlands since 1 October 2023, with 216 confirmed cases and 103 probable cases recorded till 18 January. The majority of the cases (around 80 per cent) were reported from Birmingham, with about 10 per cent in Coventry, mostly affecting children aged under 10 years. Dame Jenny is calling on all local areas to increase MMR vaccine uptake rates in communities across the country.

Former Health Secretary Alan Milburn has been appointed as the lead non-executive member of the Department of Health and Social Care's (DHSC) board to support the government's ambitious NHS reform agenda. He will succeed Samantha Jones, who has served as a non-executive director since February 2023. Milburn, known for his successful track record in reducing NHS waiting lists and improving patient satisfaction, will offer advice to help rebuild an NHS fit for the future. Expressing his enthusiasm to be appointed to this role, Milburn said, "Having spent three decades working in health policy, I have never seen the NHS in a worse state. Big reforms will be needed to make it fit for the future. "I am confident this government has the right plans in place to transform the health service and the health of the nation. "I'm looking forward to working with them to achieve that mission."

The UK Health Security Agency (UKHSA) is set for two major leadership transitions, four years after its establishment. Dame Jenny Harries has announced she will step down as UKHSA chief executive in early summer. Meanwhile, UKHSA's chief scientific officer, Professor Isabel Oliver, has been appointed chief medical officer for Wales, succeeding Sir Frank Atherton following his retirement. Appointed in April 2021 as UKHSA's first chief executive, Dame Jenny played a pivotal role in creating the agency during the COVID-19 pandemic. Under her leadership, UKHSA developed specialist scientific, data, and operational expertise to safeguard the public from infectious diseases and other health threats. Reflecting on her tenure, Dame Jenny expressed immense pride in UKHSA's early achievements.

Both head of customer operations Dan Britton and chief executive Michael Brodie at the NHS Business Services Authority (NHSBSA) have won the Inspiring Leaders Award, which recognises leaders for their humanity and courage. The coveted award, organised by Inspiring Workplaces, recognised their contribution during the pandemic. Under Brodie's leadership, who joined the organisation as chief executive in September 2019, NHSBSA started over 50 new services to support the wider NHS. He also led Public Health England (PHE) through its transition to the new UK Health Security Agency. Miranda Sykes, head of communications and marketing at NHSBSA said: "Michael is an inspirational leader for many reasons. He cares immensely and he's spent the pandemic thinking about others and using his influence to support the NHS over the last 18 months or so." His decision to take up an additional CEO role while transforming the PHE during the pandemic shows "Michael's style of leadership is authentic, inclusive and empathetic. He is passionate about the NHS and doing everything he can to support it."

The pharmacy bodies have expressed a deep concern over Lloyds Pharmacy's announcement on plans to close all pharmacy branches located in Sainsbury's before the end of 2023. Pharmaceutical Services Negotiating Committee (PSNC) Chief Executive Janet Morrison said: "This significant shrinkage by the second largest pharmacy chain is an extremely worrying development and one of the clearest signals yet of just how much all community pharmacies are struggling to make ends meet. We know that many are at breaking point." She added: "We understand that LloydsPharmacy will be in touch directly with affected staff and patients at this difficult time. As these pharmacies close, other pharmacies locally will be braced for even more pressures as they try to cope with increased demand." "The announcement by LloydsPharmacy will be of concern to staff, patients, the public and the community pharmacy sector alike," Malcolm Harrison, Chief Executive of the Company Chemists' Association (CCA). Pharmacists, and other employees, working at pharmacies owned and operated by LloydsPharmacy in Sainsbury's have been told that the group of more than 200 pharmacies will be closed this year as LloydsPharmacy will be ending their relationship with the supermarket chain.

The community pharmacy bodies, along with England's largest pharmacy chains, have urged the Prime Minister, Rishi Sunak to resolve fund and workforce crisis in the sector. In the joint letter the Chief Executives of Association of Independent Multiple Pharmacies (AIMp), Company Chemists' Association (CCA), National Pharmacy Association (NPA) and Pharmaceutical Services Negotiating Committee (PSNC), along with Boots, Lloydspharmacy, Well and Rowlands Pharmacy, said they are pleased to see Government now recognising the key role that community pharmacy' could have in alleviating the strain on other NHS services. However, the associations also warn that although the sector is ready to support, 'this will not be possible unless pharmacy is properly funded.' Janet Morrison, PSNC Chief Executive, said: "The Prime Minister should also know that community pharmacies are also facing a crisis. They need sustainable investment, urgently, if we are to avoid devasting consequences for pharmacies and for their patients." The letter calls on Government to help pharmacy to resolve the funding, workforce and capacity issues engulfing the sector. It said: "Community pharmacies are in crisis and after 7 years of 30% funding cuts have reached their limit."

Pharmacy bodies and MPs discussed on support needed to unlock the "full potential" of community pharmacy at the All Pharmacy Party Group (APPG)'s general meeting held in Westminster on Tuesday (01 November). The attendees of the meeting were Janet Morrison OBE, Chief Executive of Pharmaceutical Services Negotiating Committee; Malcolm Harrison, Chief Executive of The Company Chemists' Association; Thorrun Govind, Chair of the Royal Pharmaceutical Society; Sanjeev Panesar, National Pharmacy Association Board Member, and Pharmacist Superintendent and Owner of the Pan Pharmacy Group; and Sandeep Dhami, Association of Independent Multiple Pharmacies member and superintendent at MW Phillips Chemist At the session, 18 parliamentarians were briefed on the myriad of ways pharmacies contribute to the health of the nation. The panel of experts also highlighted that pharmacists are 'running out of fuel' with the growing challenges such as flat funding, workforce shortages and the cost-of-living crisis impacting pharmacies' ability to deliver vital services.

An Indian court has sentenced two pharmaceutical company executives to two-and-half years in jail for exporting substandard drugs to Vietnam a decade ago, months after the WHO linked their cough syrups to the deaths of children in Gambia. India suspended production at Maiden Pharmaceuticals in October last year for violations of manufacturing standards after the World Health Organization said four of its cough syrups may have killed dozens of children in Gambia. The company has denied its drugs were at fault for the deaths in Gambia and tests by an Indian government laboratory found there were no toxins in them. The company had been facing legal difficulties for years over suspected shoddy products. A court in Sonipat, near New Delhi, where Maiden has its main production facility, ordered jail for company founder Naresh Kumar Goel and technical director M.K. Sharma for exporting heartburn medicine "not of standard quality" to Vietnam.

The General Pharmaceutical Council (GPhC) has announced the names of five new members who will be joining its governing Council over the next two years. The new council members are: Professor Dianne Ford, Pro Vice-Chancellor of the Faculty of Health and Life Sciences at Northumbria University. Gareth Powell, a chartered accountant and a Non-Executive Director on the Board of the Port of Milford Haven, the UK's largest energy port. Adeyemi (Ade) Williams MBE, Superintendent Pharmacist and Director of the M J Williams Pharmacy and lead Pharmacist at the Bedminster Pharmacy, Bristol. Tim Jaggard, Deputy Chief Executive and Chief Financial Officer at University College London Hospitals NHS Foundation Trust. Dr Raliat Onatade, Chief Pharmacist and Director of Medicines and Pharmacy for North-East London Integrated Care System. Professor Ford, Powell and Williams will begin their terms on 1 April 2024, replacing Jo Kember, Mark Hammond and Arun Midha.

Stephen Kinnock, Minister of State at the Department of Health and Social Care (DHSC), discussed all primary care contracts, including those related to community pharmacy, during his meeting with Community Pharmacy England (CPE) Chief Executive and two members from the Negotiating Team. The pharmacy minister reiterated that community pharmacies will be central to the new government's health and wider missions. CPE Chief Executive Janet Morrison and her team updated Kinnock on the community pharmacy sector, highlighting the pressures throughout the summer. They underscored the critical challenges facing the sector and the urgent need for a funding lift. They also discussed Pharmacy First and emphasised the broader potential for pharmacies to further support the health of their local communities.

Pharmacy teams across the country are joining forces for the second day of protest, organised by the National Pharmacy Association (NPA), as part of its #SaveOurPharmacies campaign, on Thursday (September 19). A cross-sector delegation will present a petition signed by a record-breaking 350,000 people to No 10 Downing Street. The delegation will include National Pharmacy Association (NPA) CEO Paul Rees, NPA Chair Nick Kaye, Community Pharmacy England (CPE) Chief Executive Janet Morrison, Company Chemists' Association (CCA) CEO Malcolm Harrison, and Community Pharmacy NI Chief Executive Gerard Greene, The Save Our Pharmacies petition has surpassed the previous record held by a Royal College of GPs in 2014, whose petition, addressing the issue of general practice funding, secured 300,000 signatures. The NPA is hopeful that this show of solidarity by pharmacy teams will make a difference and open up conversations in Westminster and Whitehall.